Human Hendra virus encephalitis associated with equine outbreak, Australia, 2008

Emerging Infectious Diseases

Volumn 16, Issue 2, 2010, Pages 219-223

  Playford, Elliott G ^a,b,e   McCall, Brad ^b,d   Smith, Greg ^c   Slinko, Vicki ^d   Allen, George ^e   Smith, Ina ^c   Moore, Frederick ^c   Taylor, Carmel ^c   Kung, Yu Hsin ^f   Field, Hume ^f  

^a Pathology Queensland   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c Queensland Health   (Australia)

^d Brisbane South Public Health   (Australia)

^e PRINCESS ALEXANDRA HOSPITAL   (Australia)

^f DEPARTMENT OF AGRICULTURE AND FISHERIES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DEXAMETHASONE; RIBAVIRIN; VIRUS RNA;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; ATAXIA; AUSTRALIA; AUTOPSY; CASE REPORT; CEREBROSPINAL FLUID; CONFUSION; DIFFUSION WEIGHTED IMAGING; DISEASE COURSE; ELECTROENCEPHALOGRAM; EPIDEMIC; FEMALE; FEVER; GENETIC HETEROGENEITY; GLUCOSE BLOOD LEVEL; HEADACHE; HENDRA VIRUS; HUMAN; INCUBATION TIME; INFLUENZA; LEUKOCYTE COUNT; MALE; MYALGIA; NASOPHARYNGEAL ASPIRATION; NEUTROPENIA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTEIN BLOOD LEVEL; PTOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; THORAX RADIOGRAPHY; THROMBOCYTOPENIA; TONIC CLONIC SEIZURE; VIRUS ENCEPHALITIS; VIRUS ISOLATION; WESTERN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS;

ADULT; ANIMALS; CONTACT TRACING; DISEASE OUTBREAKS; ENCEPHALITIS; FATAL OUTCOME; FEMALE; HENDRA VIRUS; HENIPAVIRUS INFECTIONS; HORSE DISEASES; HORSES; HUMANS; MALE; QUEENSLAND; YOUNG ADULT;

EID: 76149099580     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1602.090552     Document Type: Article

References (21)

1. Field HE, Mackenzie JS, Daszak P. Henipaviruses: emerging paramyxoviruses associated with fruit bats. Curr Top Microbiol Immunol. 2007;315:133-59. DOI: 10.1007/978-3-540-70962-6-7
2. Selvey LA, Wells RM, McCormack JG, Ansford AJ, Murray K, Rogers RJ, et al. Infection of humans and horses by a newly described morbillivirus. Med J Aust. 1995;162:642-5.
3. O'Sullivan JD, Allworth AM, Paterson DL, Snow TM, Boots R, Gleeson LJ, et al. Fatal encephalitis due to novel paramyxovirus transmitted from horses. Lancet. 1997;349:93-5. DOI: 10.1016/ S0140-6736(96)06162-4
4. Field HE, Breed AC, Shield J, Hedlefs RM, Pittard K, Pott B, et al. Epidemiological perspectives on Hendra virus infection in horses and flying foxes. Aust Vet J. 2007;85:268-70. DOI: 10.1111/j.1751-0813.2007.00170.x
5. Hanna JN, McBride WJ, Brookes DL, Shield J, Taylor CT, Smith IL, et al. Hendra virus infection in a veterinarian. Med J Aust. 2006;185:562-4.
6. Animal Health Australia. Hendra virus infection, 2008 [cited 2009 Mar 13]. http://www.animalhealthaustralia.com.au/aahc/index. cfm?FD6EEF83-DCE0-A60D- 6160-20719E86C1CE
7. Smith IL, Halpin K, Warrilow D, Smith GA. Development of a fluorogenic RT-PCR assay (TaqMan) for the detection of Hendra virus. J Virol Methods. 2001;98:33-40. DOI: 10.1016/S0166-0934-(01)00354-8
8. Bossart KN, McEachern JA, Hickey AC, Choudhry V, Dimitrov DS, Eaton BT, et al. Neutralization assays for differential henipavirus serology using Biol-Plex protein array systems. J Virol Methods. 2007;142:29-40. DOI: 10.1016/j.jviromet.2007.01.003
9. Shigeta S, Mori S, Baba M, Ito M, Honzumi K, Nakamura K, et al. Antiviral activities of ribavirin, 5-ethynyl-1-beta-D-ribofuranosylimidazole-4- carboxamide, and 6′-(R)-6′-C-methylneplanocin A against several ortho- and paramyxoviruses. Antimicrob Agents Chemother. 1992;36:435-9.
10. Sarji SA, Abdullah BJ, Goh KJ, Tan CT, Wong KT. MR imaging features of Nipah encephalitis. AJR Am J Roentgenol. 2000;175:437-42.
11. Lee KE, Umapathi T, Tan CB, Tjia HT, Chua TS, Oh HM, et al. The neurological manifestations of Nipah virus encephalitis, a novel paramyxovirus. Ann Neurol. 1999;46:428-32. DOI: 10.1002/1531-8249(199909)46:3〈428::AID- ANA23〉3.0.CO;2-I
12. Hooper P, Zaki S, Daniels P, Middleton D. Comparative pathology of the diseases caused by Hendra and Nipah viruses. Microbes Infect. 2001;3:315-22. DOI: 10.1016/S1286-4579(01)01385-5
13. Eaton BT, Broder CC, Middleton D, Wang L. Hendra and Nipah viruses: different and dangerous. Nat Rev Microbiol. 2006;4:23-35. DOI: 10.1038/nrmicro1323
14. Rodriguez JJ, Horvath CM. Host evasion by emerging paramyxoviruses: Hendra virus and Nipah virus v proteins inhibit interferon signaling. Viral Immunol. 2004;17:210-9. DOI: 10.1089/0882824041310568
15. Tan CT, Goh KJ, Wong KT, Sarji SA, Chua KB, Chew NK, et al. Relapsed and late-onset Nipah encephalitis. Ann Neurol. 2002;51:703-8. DOI: 10.1002/ana.10212
16. Wright PJ, Crameri G, Eaton BT. RNA synthesis during infection by Hendra virus: an examination by quantitative real-time PCR of RNA accumulation, the effect of ribavirin and the attenuation of transcription. Arch Virol. 2005;150:521-32. DOI: 10.1007/s00705-004-0417-5
17. Chong HT, Kamarulzaman A, Tan CT, Goh KJ, Thayaparan T, Kunjapan SR, et al. Treatment of acute Nipah encephalitis with ribavirin. Ann Neurol. 2001;49:810-3. DOI: 10.1002/ana.1062
18. McCormick JB, King IJ, Webb PA, Scribner CL, Craven RB, Johnson KM, et al. Lassa fever. Effective therapy with ribavirin. N Engl J Med. 1986;314:20-6.
19. Georges-Courbot MC, Contamin H, Faure C, Loth P, Baize S, Leyssen P, et al. Poly(I)-poly(C12U) but not ribavirin prevents death in a hamster model of Nipah virus infection. Antimicrob Agents Chemother. 2006;50:1768-72. DOI: 10.1128/AAC.50.5.1768-1772.2006
20. Crowe SM. Ribavirin. In: Kucers A, Crowe SM, Grayson ML, Hoy JF, editors. The use of antibiotics: a clinical review of antibacterial, antifungal and antiviral drugs, 5th ed. Oxford (UK): Butterworth Heinemann; 1997.
21. Bewg WG. Guidelines for veterinarians handling potential Hendra virus infection in horses. Biosecurity Queensland, Department of Primary Industries and Fisheries, Queensland Government, 2008 [cited 2008 Mar 13]. http://www.dpi.qld.gov.au/documents/ Biosecurity- GeneralAnimalHealthPestsAndDiseases/Hendra-Work-Instructions-for-Vets1010808.pdf